Accelerate to discover

Back to filter

Related topics

Genotype-targeted local therapy of glioma

Spectral Instruments Imaging

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

Cancer cells resist mechanical destruction in the circulation via RhoA-myosin II axis

Spectral Instruments Imaging

Mar 20, 2020

Tumors may generate millions of Circulating tumor cells per day, but seminal work in cancer biology has established the...

IncuCyte live cell analysis system for 3D Organoids discovery

Sartorius

Mar 18, 2020

Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...

Comparing image quality in Phase Contrast X-Ray Tomography

Bruker Biospin

Feb 28, 2020

How to evaluate and compare image quality from different submicrometer CT scans? A simple yet clever test phantom is...

Mar 28, 2020

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice

Bruker Biospin

Feb 20, 2020

MicroPET-based dosimetry of 152Tb is feasible, and the comparison with organ harvesting resulted in acceptable dose...

Travel grant ALERT! Submit ESHG abstracts today

BioNano Genomics

Feb 13, 2020

Interested in sharing your Bionano Genomics data at ESHG 2020 in Berlin? Eager to share how you have utilized the...

AutoLV analysis software

VisualSonics FujiFilm

Feb 11, 2020

AutoLV analysis software is the latest addition to VisualSonics robust suite of measurement tools customized for...

Mar 28, 2020

IncuCyte Live-Cell Analysis System - nearly 3,000 publications and counting!

Sartorius

Jan 21, 2020

IncuCyte has now reached nearly 3,000 cited publications! Search our publications filter to see what exciting research...

Show all topics (10)

Homing in on directed imaging platforms

Aug 9, 2016

At the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Anna Wu, Ph.D., professor and chair of the department of molecular and medical pharmacology, has been engineering antibodies for both therapeutic and imaging purposes. Antibodies meant for imaging, she points out, reflect a slightly different set of engineering characteristics.

Dr. Wu works with colleagues at UCLA and ImaginAb (a company she co-founded in 2007 and now serves as chief scientist) to engineer labeled antibodies. Because Dr. Wu in interested in advancing positron emission tomography (PET) imaging, she is engineering antibodies that incorporate positron-emitting radionucleotides.

“Each imaging modality has its strengths and weaknesses,” notes Dr. Wu. “Magnetic resonance imaging (MRI) gives you anatomical and physiological imaging, but it doesn’t have the sensitivity of PET. PET has a higher resolution and sensitivity compared to single-photon emission computed tomography (SPECT), but it has lower resolution than MRI or CT.”

Dr. Wu has chosen PET because it fits well with her antibody fragments (called minibodies and diabodies) in a process coined immunoPET. She favors PET because it can, she says, be combined with the specificity of antibodies.

“One of the key features of antibodies is they have very long circulating half-lives,” she points out. “Antibodies stay in the blood for days to weeks.” To match the half-lives of antibodies, she and others have been testing longer-lived positron emitters, such as zirconium-89. “The fluorine-18 everyone uses has a two-hour half-life, so it’s a challenge to make a fragment that targets and clears quickly enough to image.” Zirconium-89, in contrast, has a half-life that is a little over three days.

Read more

Scientific paper

Related technologies: PET, SPECT, CT

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey